Judge Poised to End Giuliani’s Bankruptcy, Clearing Path for Multiple Lawsuits to Advance

WHITE PLAINS, N.Y. — A federal bankruptcy judge indicated Wednesday he might soon dismiss the bankruptcy case involving Rudy Giuliani, former attorney to ex-President Donald Trump. This development could reactivate several lawsuits against Giuliani, including those for defamation and sexual harassment. U.S. Bankruptcy Judge Sean Lane stated he plans to decide by Friday on the requests concerning Giuliani’s financial reorganization. Giuliani, 80, sought bankruptcy protection in December following a court mandate in Washington, D.C., to pay $148 million to two Georgia election workers he erroneously accused of vote rigging during the 2020 Presidential election. The … Read more

Surge in Lawsuits as Patients Suffering from Defective Hernia Mesh Seek Justice Across All States

Across the United U.S., thousands of lawsuits are progressing through various courts where plaintiffs claim they suffered severe complications from defective hernia mesh implants used during surgeries. The legal battles involve several major medical device manufacturers, including Ethicon, a subsidiary of Johnson & Johnson, which has already reached settlement in most of its cases. Other prominent defendants include C.R. Bard, now part of Beckton Dickinson, Covidien, and Atrium Medical Corp. At the heart of these lawsuits are allegations that the hernia meshes, which are intended to support weakened or damaged tissue, were defectively designed or … Read more

Merck Resolves Over 1,000 Zostavax Lawsuits Following Plaintiff Dismissals

Rahway, New Jersey — Merck & Co., a leading pharmaceutical company, has reached a significant legal milestone by resolving over a thousand lawsuits connected to its shingles vaccine, Zostavax. The cases were concluded following the plaintiffs’ decision to request dismissals, thus eliminating a batch of longstanding legal grievances against the drugmaker. Zostavax, designed to prevent shingles in older adults, was approved by the U.S. Food and Drug Administration in 2006. Marketed until its production ceased in 2020, it was the only shingles vaccine available in the U.S. for a decade before competitors like Shingrix emerged. … Read more

C.R. Bard Faces Over 18,000 Lawsuits as Hernia Mesh Victims Demand Justice

NEWARK, N.J. — Medical device company C.R. Bard, a subsidiary of Beckton Dickson, is currently facing a significant legal challenge with over 18,000 hernia mesh lawsuits alleging that the devices were defective, causing severe injuries to thousands of patients. Settlement discussions are underway with expectations leaning towards potential conclusions in May 2024, although some law firms have not yet reached an agreement. The litigations, which span all fifty states, surged after a Rhode Island state court rendered a $4.8 million verdict in favor of a plaintiff injured by Bard’s hernia mesh. This was closely followed … Read more